Ondrej Ludka1, Radka Stepanova2, Martina Vyskocilova2, Lujza Galkova1, Monika Mikolaskova3, Milos Belehrad2, Jana Kostalova2, Zuzana Mihalova4, Adela Drozdova4, Jiri Hlasensky3, Michal Gacik5, Lucie Pudilova5, Tereza Mikusova6, Blanka Fischerova6, Fatima Sert-Kuniyoshi7, Virend K Somers8, Jindrich Spinar1, Tomas Kara9. 1. Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic. 2. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. 3. Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic. 4. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic. 5. Faculty of Medicine, Masaryk University, Brno, Czech Republic. 6. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic; Department of Cardiovascular Disease, St. Anne's University Hospital, Brno, Czech Republic. 7. Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA. 8. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic; Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA. 9. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic; Department of Cardiovascular Disease, St. Anne's University Hospital, Brno, Czech Republic; Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA. Electronic address: Kara.Tomas@mayo.edu.
Abstract
BACKGROUND: While sleep apnea (SA) might be a modifiable cardiovascular risk factor, recent data suggest that SA is severely underdiagnosed in patients after acute myocardial infarction (MI). There is limited evidence about day-night variation of onset of MI on dependence of having SA. We therefore investigated the prevalence of SA and examined the day-night variation of onset of MI in acute MI patients. METHODS: We prospectively studied 782 consecutive patients admitted to the hospital with the diagnosis of acute MI. All subjects underwent sleep evaluations using a portable device after at least 48 h post-admission. Using the apnea-hypopnea index (AHI), groups were defined as patients without SA (<5 events/h), mild SA (5-15 events/h), moderate SA (15-30 events/h), and severe SA (≥ 30 events/h). RESULTS: Almost all patients (98%) underwent urgent coronary angiography and 91% of patients underwent primary PCI. Using a threshold of AHI ≥ 5 events/h, SA was present in 65.7% of patients after acute MI. Mild SA was present in 32.6%, moderate in 20.4% and severe in 12.7%. The day-night variation in the onset of MI in all groups of SA patients was similar to that observed in non-SA patients. From 6 AM to 12 PM, the frequency of MI was higher in both SA and non-SA patients, as compared to the interval from 12 AM to 6 AM (all p<0.05). CONCLUSION: There is a high prevalence of SA in patients presenting with acute MI. Peak time of MI onset in SA patients was between 6 AM and noon, similar to that in the general population. Whether diagnosis and treatment of SA after MI will significantly improve outcomes in these patients remains to be determined.
BACKGROUND: While sleep apnea (SA) might be a modifiable cardiovascular risk factor, recent data suggest that SA is severely underdiagnosed in patients after acute myocardial infarction (MI). There is limited evidence about day-night variation of onset of MI on dependence of having SA. We therefore investigated the prevalence of SA and examined the day-night variation of onset of MI in acute MI patients. METHODS: We prospectively studied 782 consecutive patients admitted to the hospital with the diagnosis of acute MI. All subjects underwent sleep evaluations using a portable device after at least 48 h post-admission. Using the apnea-hypopnea index (AHI), groups were defined as patients without SA (<5 events/h), mild SA (5-15 events/h), moderate SA (15-30 events/h), and severe SA (≥ 30 events/h). RESULTS: Almost all patients (98%) underwent urgent coronary angiography and 91% of patients underwent primary PCI. Using a threshold of AHI ≥ 5 events/h, SA was present in 65.7% of patients after acute MI. Mild SA was present in 32.6%, moderate in 20.4% and severe in 12.7%. The day-night variation in the onset of MI in all groups of SA patients was similar to that observed in non-SA patients. From 6 AM to 12 PM, the frequency of MI was higher in both SA and non-SA patients, as compared to the interval from 12 AM to 6 AM (all p<0.05). CONCLUSION: There is a high prevalence of SA in patients presenting with acute MI. Peak time of MI onset in SA patients was between 6 AM and noon, similar to that in the general population. Whether diagnosis and treatment of SA after MI will significantly improve outcomes in these patients remains to be determined.
Authors: V Aboyans; C Cassat; P Lacroix; P Tapie; F Tabaraud; F Pesteil; F Bertin; M Laskar; P Virot Journal: Cardiology Date: 2000 Impact factor: 1.869
Authors: J E Muller; P H Stone; Z G Turi; J D Rutherford; C A Czeisler; C Parker; W K Poole; E Passamani; R Roberts; T Robertson Journal: N Engl J Med Date: 1985-11-21 Impact factor: 91.245
Authors: R Nisha Aurora; Ciprian Crainiceanu; Daniel J Gottlieb; Ji Soo Kim; Naresh M Punjabi Journal: Am J Respir Crit Care Med Date: 2018-03-01 Impact factor: 21.405
Authors: Safal Shetty; Aaron Fernandes; Sarah Patel; Daniel Combs; Michael A Grandner; Sairam Parthasarathy Journal: J Clin Sleep Med Date: 2017-01-15 Impact factor: 4.062
Authors: Christopher A Wang; Joseph R Palmer; Michael O Madden; Wayne Cohen-Levy; Rushabh M Vakharia; Martin W Roche Journal: J Orthop Date: 2019-05-01
Authors: Antonia Barcelo; Josep Miquel Bauça; Aina Yañez; Laura Fueyo; Cristina Gomez; Monica de la Peña; Javier Pierola; Alberto Rodriguez; Manuel Sanchez-de-la-Torre; Jorge Abad; Olga Mediano; Jose Amilibia; Maria Jose Masdeu; Joaquin Teran; Josep Maria Montserrat; Mercè Mayos; Alicia Sanchez-de-la-Torre; Ferran Barbé Journal: PLoS One Date: 2016-03-01 Impact factor: 3.240